Team GP2

GP2 Visits Nigeria: Commissioning of Nigeria’s First Molecular Laboratory for Parkinson’s Disease Genetics

03/19/2026 — Located within the Kesington Adebukunola Adebutu Research Centre (KAARC), the GP2-College of Medicine University of Lagos (CMUL) Molecular Laboratory for Parkinson’s Disease Research's goal is to extract and analyze DNA from Nigerian patients on-site, ensuring that West African ancestry genetic sequences are no longer underrepresented but are instead a driving contributor to global research.

Listen: Building a Global Genetic Map of Parkinson’s with Andy Singleton and Ignacio Mata

02/10/2026 — Listen as Andy Singleton, co-lead of the Global Parkinson's Genetics Program (GP2), and Nacho Mata, Cleveland Clinic geneticist and LARGE-PD founder, discuss how GP2 is accelerating discovery and expanding global representation in Parkinson’s research.

University of Lagos Commissions Parkinson’s Disease Research Lab

01/26/2026 — The College of Medicine, University of Lagos (CMUL) has commissioned the GP2–CMUL Molecular Laboratory to strengthen Parkinson’s disease research, genomics capacity, and training opportunities across Africa in collaboration with Aligning Science Across Parkinson’s (ASAP) and the Global Parkinson’s Genetics Program (GP2).

100,000 Participants and Counting – Massive Global Genetic Dataset Powers Discoveries in Parkinson’s Disease

12/01/2025 — Researchers have reached a major milestone in the effort to understand and treat Parkinson’s disease: more than 100,000 DNA samples from study participants around the world have now been genotyped and sequenced through the Global Parkinson’s Genetics Program (GP2).

The Components of GP2’s 11th Data Release

12/01/2025 — GP2's 11th data release brings the total samples to more than 100,000 from individuals worldwide, making it one of the most comprehensive and globally representative PD datasets to date.